A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines

2009 ◽  
Vol 136 (1) ◽  
pp. 115-121 ◽  
Author(s):  
George Orphanos ◽  
Athanasios Alexopoulos ◽  
Savvoula Malliou ◽  
George Ioannidis ◽  
Alexandros Ardavanis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
Second Line ◽  
Previously Treated

Phase II study of cabazitaxel as second-line treatment in patients with HER-2 negative metastatic breast cancer previously treated with taxanes.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 1089-1089
Author(s):  
Angelos Koutras ◽  
Flora Zagouri ◽  
Georgia-Angeliki Koliou ◽  
Georgios Lazaridis ◽  
Dimitrios Tryfonopoulos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
Second Line ◽  
Previously Treated ◽  
Her 2

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

2007 ◽  
Vol 134 (2) ◽  
pp. 125-135 ◽  
Author(s):  
Martina Baur ◽  
Allan T. van Oosterom ◽  
Véronique Diéras ◽  
Michele Tubiana-Hulin ◽  
R. Charles Coombes ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document